Calculating Variations in Biological Effectiveness for a 62 MeV Proton Beam
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
A biophysical model of radiation-induced cell death and chromosome aberrations [called BIophysical ANalysis of Cell death and chromosome Aberrations (BIANCA)] was further developed and applied to therapeutic protons. The model assumes a pivotal role of DNA cluster damage, which can lead to clonogenic cell death following three main steps: (i) a DNA "cluster lesion" (CL) produces two independent chromosome fragments; (ii) fragment mis-rejoining within a threshold distance d gives rise to chromosome aberrations; (iii) certain aberration types (dicentrics, rings, and large deletions) lead to clonogenic inactivation. The yield of CLs and the probability, f, that a chromosome fragment remains un-rejoined even if other fragment(s) are present within d, were adjustable parameters. The model, implemented as a MC code providing simulated dose-responses directly comparable with experimental data, was applied to pristine and modulated Bragg peaks of the proton beam used to treat eye melanoma at INFN-LNS in Catania, Italy. Experimental survival curves for AG01522 cells exposed to the Catania beam were reproduced, supporting the model assumptions. Furthermore, cell death and chromosome aberrations at different depths along a spread-out Bragg peak (SOBP) dose profile were predicted. Both endpoints showed an increase along the plateau, and high levels of damage were found also beyond the distal dose fall-off, due to low-energy protons. Cell death and chromosome aberrations were also predicted for V79 cells, in the same irradiation scenario as that used for AG01522 cells. In line with other studies, this work indicated that assuming a constant relative biological effectiveness (RBE) along a proton SOBP may be sub-optimal. Furthermore, it provided qualitative and quantitative evaluations of the dependence of the beam effectiveness on the considered endpoint and dose. More generally, this work represents an example of therapeutic beam characterization avoiding the use of experimental RBE values, which can be source of uncertainties.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A model of chromosome aberration induction: applications to space research
Ballarini, F., & Ottolenghi, A. (2005) · Radiation Research · doi:10.1667/rr3365.1 · Cited by 33
Self-citation
Cited by
Carante, M. P., Aimè, C., Cajiao, J. J. T., & Ballarini, F. (2018) · Physics in Medicine & Biology · doi:10.1088/1361-6560/aab45f · Cited by 52
Self-citationChromosome aberrations and cell death by ionizing radiation: evolution of a biophysical model
Ballarini, F., & Carante, M. P. (2016) · Radiation Physics and Chemistry · doi:10.1016/j.radphyschem.2016.06.009 · Cited by 45
Self-citationProximity effects in chromosome aberration induction by low-LET ionizing radiation
Tello Cajiao, J. J., Carante, M. P., Bernal Rodriguez, M. A., & Ballarini, F. (2017) · DNA Repair · doi:10.1016/j.dnarep.2017.08.007 · Cited by 25
Self-citationCarante, M. P., Aricò, G., Ferrari, A., Kozlowska, W., Mairani, A., & Ballarini, F. (2019) · Physics in Medicine & Biology · doi:10.1088/1361-6560/ab490f · Cited by 23
Self-citationIn vivo validation of the BIANCA biophysical model: benchmarking against rat spinal cord RBE data
Carante, M. P., Aricò, G., Ferrari, A., Karger, C. P., Kozlowska, W., Mairani, A., Sala, P., & Ballarini, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113973 · Cited by 21
Self-citation
Metadata
- Authors
- Carante, M. P., & Ballarini, F.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2016-04-06
- Volume
- 6
- Pages
- 76-76
- ISSN
- 2234-943X (ISSN-L)
- OpenAlex
- W2313723515
- Cited by
- 26
- References
- 1
- FWCI
- 3.97
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.